The global Sufentanil (API) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Sufentanil (API) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sufentanil (API) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Sufentanil (API) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Sufentanil (API) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Kern Pharma
Cambrex
Hameln Rds
Cristalia
Janssen Pharmaceuticals
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Purity 98%
Purity 99%

Segment by Application
Injection
Capsule